Medical Imaging Markets: Contrast Agents
NEW YORK, Aug. 6, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Today's capabilities in clinical diagnostic radiology have been made possible by advances not only in diagnostic systems, but also by the contrast media and radiopharmaceuticals that make it possible to see, in great detail, the body's internal structures, organs and tissue that would not otherwise be clearly seen. Although bones are readily apparent on radiographic images, other organs and tissues are not. These imaging agents may be used during a medical imaging procedure to highlight specific parts of the body and make them easier to visualize. The application and versatility of medical imaging modalities are continuing to grow in significance as the population ages and healthcare costs rise. Examinations that can facilitate earlier disease diagnosis and the most appropriate treatment are in order. This bodes well for contrast media markets.
Generally, the market for contrast agents and radiopharmaceuticals is expected to sustain decent growth in the next few years, with much of that growth coming from the MRI, ultrasound and nuclear medicine modalities. While equipment manufacturers may have experienced a slump in sales due to the recent recession, there is still a need for these agents,as well as for radiopharmaceuticals, to help image, track and diagnose disease, especially in